223 related articles for article (PubMed ID: 35409062)
1. A Comparison of Network-Based Methods for Drug Repurposing along with an Application to Human Complex Diseases.
Fiscon G; Conte F; Farina L; Paci P
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409062
[TBL] [Abstract][Full Text] [Related]
2. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
Firoozbakht F; Rezaeian I; Rueda L; Ngom A
BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
[TBL] [Abstract][Full Text] [Related]
3. SAveRUNNER: an R-based tool for drug repurposing.
Fiscon G; Paci P
BMC Bioinformatics; 2021 Mar; 22(1):150. PubMed ID: 33757425
[TBL] [Abstract][Full Text] [Related]
4. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
[TBL] [Abstract][Full Text] [Related]
5. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
6. Network-based approach for drug repurposing against mpox.
Tang K; Sun Q; Zeng J; Tang J; Cheng P; Qiu Z; Long H; Chen Y; Zhang C; Wei J; Qiu X; Jiang G; Fang Q; Sun L; Sun C; Du X
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132468. PubMed ID: 38761900
[TBL] [Abstract][Full Text] [Related]
7. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
8. Exploring the potential of drug repurposing for liver diseases: A comprehensive study.
Ali FEM; Abdel-Reheim MA; Hassanein EHM; Abd El-Aziz MK; Althagafy HS; Badran KSA
Life Sci; 2024 Jun; 347():122642. PubMed ID: 38641047
[TBL] [Abstract][Full Text] [Related]
9. A machine learning and network framework to discover new indications for small molecules.
Gilvary C; Elkhader J; Madhukar N; Henchcliffe C; Goncalves MD; Elemento O
PLoS Comput Biol; 2020 Aug; 16(8):e1008098. PubMed ID: 32764756
[TBL] [Abstract][Full Text] [Related]
10. Network medicine for disease module identification and drug repurposing with the NeDRex platform.
Sadegh S; Skelton J; Anastasi E; Bernett J; Blumenthal DB; Galindez G; Salgado-Albarrán M; Lazareva O; Flanagan K; Cockell S; Nogales C; Casas AI; Schmidt HHHW; Baumbach J; Wipat A; Kacprowski T
Nat Commun; 2021 Nov; 12(1):6848. PubMed ID: 34824199
[TBL] [Abstract][Full Text] [Related]
11. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Alaimo S; Pulvirenti A
Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
[TBL] [Abstract][Full Text] [Related]
12. Current approaches in identification of a novel drug targets for drug repurposing.
Khambhati K; Singh V
Prog Mol Biol Transl Sci; 2024; 205():213-220. PubMed ID: 38789179
[TBL] [Abstract][Full Text] [Related]
13. Computational biology approaches for drug repurposing.
Waseem T; Rajput TA; Mushtaq MS; Babar MM; Rajadas J
Prog Mol Biol Transl Sci; 2024; 205():91-109. PubMed ID: 38789189
[TBL] [Abstract][Full Text] [Related]
14. Candidates for drug repurposing to address the cognitive symptoms in schizophrenia.
Koch E; Kauppi K; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110637. PubMed ID: 36099967
[TBL] [Abstract][Full Text] [Related]
15. Computational drug repositioning through heterogeneous network clustering.
Wu C; Gudivada RC; Aronow BJ; Jegga AG
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
[TBL] [Abstract][Full Text] [Related]
16. NMSDR: Drug repurposing approach based on transcriptome data and network module similarity.
Ünsal Ü; Cüvitoğlu A; Turhan K; Işık Z
Mol Inform; 2023 Mar; 42(3):e2200077. PubMed ID: 36411244
[TBL] [Abstract][Full Text] [Related]
17. A novel computational approach for drug repurposing using systems biology.
Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing Analysis for Colorectal Cancer through Network Medicine Framework: Novel Candidate Drugs and Small Molecules.
Unal U; Gov E
Cancer Invest; 2023 Sep; 41(8):713-733. PubMed ID: 37682113
[TBL] [Abstract][Full Text] [Related]
19. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
[TBL] [Abstract][Full Text] [Related]
20. Gene co-expression in the interactome: moving from correlation toward causation via an integrated approach to disease module discovery.
Paci P; Fiscon G; Conte F; Wang RS; Farina L; Loscalzo J
NPJ Syst Biol Appl; 2021 Jan; 7(1):3. PubMed ID: 33479222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
